PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PULSE BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$47.55+3.12 (+7.02%)
Close on Oct 19, 2026
- Market cap
- $3.29B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
15.0%
11M of 71M shares
Institutional holders
106
22 new, 10 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
8 buys · 7 sales
Net bought $23.86M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Robert W. Duggan | 49,706,423 | 71.90% | 13D (active) amendment | May 11, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PLSE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,466,702 | 2.06% | $40.67M | +126,924 | 0.00% |
| Bank Of America Corp /De/ | 1,446,611 | 2.03% | $40.11M | +580,550 | 0.00% |
| Vanguard Capital Management LLC | 788,640 | 1.11% | $21.87M | −27,212 | 0.00% |
| Portolan Capital Management, LLC | 753,333 | 1.06% | $20.89M | +19,961 | 0.78% |
| Price T Rowe Associates Inc /Md/ | 748,638 | 1.05% | $20.76K | +733,779 | 0.00% |
| Balyasny Asset Management L.P. | 718,103 | 1.01% | $19.91M | +452,939 | 0.02% |
| Citadel Advisors LLC | 626,514 | 0.88% | $17.37M | +484,364 | 0.00% |
| Geode Capital Management, LLC | 536,276 | 0.75% | $14.87M | +44,330 | 0.00% |
| State Street Corp | 529,624 | 0.74% | $14.69M | +72,697 | 0.00% |
| Massachusetts Financial Services Co /Ma/ | 462,734 | 0.65% | $12.83M | −165 | 0.00% |
| UBS Group AG | 275,669 | 0.39% | $7.64M | +241,715 | 0.00% |
| Griffin Asset Management, Inc. | 227,285 | 0.32% | $6.30M | +2,108 | 0.66% |
| Vanguard Portfolio Management LLC | 179,497 | 0.25% | $4.98M | +14,296 | 0.00% |
| Northern Trust Corp | 173,590 | 0.24% | $4.81M | −13,682 | 0.00% |
| Charles Schwab Investment Management Inc | 151,991 | 0.21% | $4.21M | +4,223 | 0.00% |
| Vanguard Fiduciary Trust Co | 131,253 | 0.18% | $3.64M | +647 | 0.00% |
| Point72 Asset Management, L.P. | 106,457 | 0.15% | $2.95M | New | 0.00% |
| Norges Bank | 105,647 | 0.15% | $2.93M | New | 0.00% |
| Nuveen, LLC | 101,683 | 0.14% | $2.82M | +56,248 | 0.00% |
| Panoramic Capital, LLC | 98,054 | 0.14% | $2.72M | +40,000 | 1.17% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 106 | 11M | 15.0% | 22 / 43 | 23 / 10 | 3M | 0M |
| Q1 2026 | 96 | 8M | 10.9% | 33 / 27 | 23 / 15 | 3M | 0M |
| Q4 2025 | 82 | 6M | 8.9% | 11 / 24 | 27 / 13 | 1M | 0M |
| Q3 2025 | 84 | 6M | 8.2% | 10 / 26 | 27 / 12 | 0M | 0M |
| Q2 2025 | 86 | 6M | 8.4% | 11 / 30 | 28 / 9 | 1M | 0M |
| Q1 2025 | 84 | 6M | 8.0% | 18 / 23 | 29 / 6 | 1M | 1M |
| Q4 2024 | 73 | 6M | 8.4% | 13 / 31 | 17 / 12 | 1M | 0M |
| Q3 2024 | 72 | 6M | 7.9% | 20 / 23 | 17 / 3 | 2M | 0M |
| Q2 2024 | 57 | 5M | 6.8% | 8 / 24 | 17 / 12 | 0M | 0M |
| Q1 2024 | 61 | 5M | 6.8% | 14 / 11 | 23 / 3 | 1M | 0M |
| Q4 2023 | 50 | 4M | 6.3% | 11 / 17 | 12 / 4 | 1M | 0M |
| Q3 2023 | 43 | 4M | 5.4% | 4 / 17 | 12 / 5 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PLSE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 554,612 | 0.78% | $15.38M | 0.00% | Jun 30, 2026 |
| Strategic Advisers U.S. Total Stock Fund | 513,041 | 0.72% | $12.83M | 0.01% | May 31, 2026 |
| iShares Russell 2000 ETF | 487,179 | 0.68% | $13.51M | 0.02% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 485,300 | 0.68% | $13.46M | 0.09% | Jun 30, 2026 |
| MFS New Discovery Fund | 339,453 | 0.48% | $8.49M | 0.40% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 215,880 | 0.30% | $5.99M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 210,120 | 0.29% | $7.38M | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 174,265 | 0.24% | $4.83M | 0.03% | Jun 30, 2026 |
| MFS New Discovery Series | 122,295 | 0.17% | $3.39M | 0.41% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 94,628 | 0.13% | $2.37M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 91,223 | 0.13% | $2.28M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 86,743 | 0.12% | $2.17M | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 61,907 | 0.09% | $1.72M | 0.11% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 60,556 | 0.08% | $1.51M | 0.01% | May 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF | 53,019 | 0.07% | $1.47M | 0.97% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul A. Laviolette | Chief Executive Officer, Director | 15,000 | 0.02% | May 11, 2026 |
| Darrin Uecker | Chief Technology Officer, Director | 142,872 | 0.20% | Apr 3, 2026 |
| Liane Rae Teplitsky | Chief Operating Officer | 4,095 | 0.01% | Sep 2, 2026 |
| Jon Skinner | Chief Financial Officer | – | – | Aug 28, 2026 |
| Kevin Patrick Danahy | Chief Commercial Officer | 43,298 | 0.06% | Feb 23, 2026 |
| Steven Weber | Principal Accounting Officer | – | – | Jul 16, 2025 |
| Mahkam Zanganeh | Director | 873,469 | 1.22% | Jun 15, 2026 |
| Manmeet Singh Soni | Director | – | – | Jun 15, 2026 |
| Robert W. Duggan | Director, 10% owner | 49,450,345 | 69.33% | Jun 15, 2026 |
| Maria Sainz | Director | – | – | Jun 15, 2026 |
| den Broek Richard van | Director | – | – | Jun 15, 2026 |
| Burke Thomas Barrett | – | 63,172 | 0.09% | Dec 20, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Liane Rae Teplitsky Chief Operating Officer | Sep 1, 2026 | Buy | +1,001 | $49.95 | $50.00K | 4,095 |
| Liane Rae Teplitsky Chief Operating Officer | Aug 31, 2026 | Buy | +1,024 | $48.80 | $49.97K | 3,094 |
| Liane Rae Teplitsky Chief Operating Officer | Aug 28, 2026 | Buy | +1,034 | $48.35 | $49.99K | 2,070 |
| Liane Rae Teplitsky Chief Operating Officer | Aug 26, 2026 | Buy | +1,036 | $48.24 | $49.98K | 1,036 |
| Robert W. Duggan Director, 10% owner | May 11, 2026 | Buy | +660,233 | $19.69 | $13.00M | 48,370,047 |
| Paul A. Laviolette Chief Executive Officer, Director | May 11, 2026 | Buy | +15,000 | $19.69 | $295.35K | 15,000 |
| Robert W. Duggan Director, 10% owner | May 11, 2026 | Buy | +660,233 | $19.69 | $13.00M | 48,211,433 |
| Paul A. Laviolette Chief Executive Officer, Director | May 11, 2026 | Buy | +15,000 | $19.69 | $295.35K | 15,846 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 18, 2026 | Sale(10b5-1 plan) | −5,000 | $23.64 | $118.20K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 18, 2026 | Option exercise | +5,000 | $1.53 | $7.65K | 48,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 17, 2026 | Sale(10b5-1 plan) | −20,000 | $23.63 | $472.60K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 17, 2026 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 13, 2026 | Sale(10b5-1 plan) | −20,000 | $23.53 | $470.60K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 13, 2026 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 12, 2026 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 12, 2026 | Sale(10b5-1 plan) | −20,000 | $23.37 | $467.40K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 11, 2026 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 11, 2026 | Sale(10b5-1 plan) | −20,000 | $25.20 | $504.00K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 10, 2026 | Sale(10b5-1 plan) | −20,000 | $23.52 | $470.40K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 10, 2026 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 9, 2026 | Sale(10b5-1 plan) | −20,000 | $21.45 | $429.00K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Feb 9, 2026 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Oct 2, 2025 | Option exercise | +4,600 | $1.53 | $7.04K | 47,898 |
| Kevin Patrick Danahy Chief Commercial Officer | Oct 2, 2025 | Sale(10b5-1 plan) | −4,600 | $18.53 | $85.24K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Sep 19, 2025 | Option exercise | +400 | $1.53 | $612 | 43,698 |
| Kevin Patrick Danahy Chief Commercial Officer | Sep 19, 2025 | Sale(10b5-1 plan) | −400 | $18.48 | $7.39K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Sep 18, 2025 | Sale(10b5-1 plan) | −20,000 | $18.49 | $369.80K | 43,298 |
| Kevin Patrick Danahy Chief Commercial Officer | Sep 18, 2025 | Option exercise | +20,000 | $1.53 | $30.60K | 63,298 |
| Darrin Uecker Chief Technology Officer, Director | Sep 17, 2025 | Option exercise | +20,000 | $4.00 | $80.00K | 142,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 17, 2025 | Option exercise | +61,534 | $4.00 | $246.14K | 184,406 |
| Darrin Uecker Chief Technology Officer, Director | Sep 17, 2025 | Sale(10b5-1 plan) | −20,000 | $16.21 | $324.20K | 122,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 17, 2025 | Option exercise | +100,000 | $4.00 | $400.00K | 284,406 |
| Darrin Uecker Chief Technology Officer, Director | Sep 16, 2025 | Sale(10b5-1 plan) | −25,000 | $16.28 | $407.00K | 122,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 16, 2025 | Option exercise | +25,000 | $4.00 | $100.00K | 147,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 15, 2025 | Option exercise | +25,000 | $4.00 | $100.00K | 147,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 15, 2025 | Sale(10b5-1 plan) | −25,000 | $15.77 | $394.25K | 122,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 12, 2025 | Option exercise | +25,000 | $4.00 | $100.00K | 147,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 12, 2025 | Sale(10b5-1 plan) | −25,000 | $14.32 | $358.00K | 122,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 11, 2025 | Sale(10b5-1 plan) | −25,000 | $14.78 | $369.50K | 122,872 |
| Darrin Uecker Chief Technology Officer, Director | Sep 11, 2025 | Option exercise | +25,000 | $4.00 | $100.00K | 147,872 |
| Robert W. Duggan Director, 10% owner | Sep 10, 2025 | Buy | +34,659 | $14.66 | $508.10K | 47,551,200 |
| Darrin Uecker Chief Technology Officer, Director | Jun 13, 2025 | Sale | −15,000 | $15.98 | $239.70K | 122,872 |
| Darrin Uecker Chief Technology Officer, Director | Jun 12, 2025 | Sale | −15,000 | $16.40 | $246.00K | 137,872 |
| Mahkam Zanganeh Director | Feb 3, 2025 | Option exercise | +30,121 | $11.00 | $331.33K | 725,395 |
| Mahkam Zanganeh Director | Jan 24, 2025 | Option exercise | +30,121 | $11.00 | $331.33K | 695,274 |
| Robert W. Duggan Director, 10% owner | Dec 18, 2024 | Option exercise | +49,312 | $11.00 | $542.43K | 450,189 |
| Robert W. Duggan Director, 10% owner | Dec 18, 2024 | Option exercise | +69,020 | $11.00 | $759.22K | 630,109 |
| Robert W. Duggan Director, 10% owner | Dec 18, 2024 | Option exercise | +5,187,824 | $11.00 | $57.07M | 47,516,541 |
| Robert W. Duggan Director, 10% owner | Dec 13, 2024 | Buy | +55,256 | $17.18 | $949.30K | 42,328,717 |
| Robert W. Duggan Director, 10% owner | Dec 12, 2024 | Buy | +45,404 | $17.13 | $777.77K | 42,273,461 |
| Burke Thomas Barrett – | Dec 11, 2024 | Sale | −50,000 | $17.42 | $871.00K | 63,172 |
| Robert W. Duggan Director, 10% owner | Dec 11, 2024 | Buy | +50,000 | $17.42 | $871.00K | 42,228,057 |
| Robert W. Duggan Director, 10% owner | Dec 11, 2024 | Buy | +6,054 | $16.74 | $101.34K | 42,178,057 |
| Mitchell E. Levinson Chief Strategy Officer | Sep 24, 2024 | Option exercise | +3,000 | $11.00 | $33.00K | 93,880 |
| Mitchell E. Levinson Chief Strategy Officer | Sep 24, 2024 | Option exercise | +1,240 | $11.00 | $13.64K | 21,240 |
| Mitchell E. Levinson Chief Strategy Officer | Sep 24, 2024 | Option exercise | +322 | $11.00 | $3.54K | 8,321 |
| Mitchell E. Levinson Chief Strategy Officer | Sep 24, 2024 | Option exercise | +322 | $11.00 | $3.54K | 8,421 |
| Mitchell E. Levinson Chief Strategy Officer | Sep 24, 2024 | Option exercise | +322 | $11.00 | $3.54K | 8,521 |
| Robert W. Duggan Director, 10% owner | Sep 12, 2024 | Buy | +145,140 | $14.41 | $2.09M | 47,709,140 |
| Robert W. Duggan Director, 10% owner | Sep 11, 2024 | Buy | +12,800 | $14.77 | $189.06K | 47,564,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Danahy Kevin Officer | Feb 12, 2026 | 50,000 | $1.26M | Feb 12, 2026 | Exercise of Stock Options |
| Danahy Kevin Officer | Feb 9, 2026 | 75,000 | $1.56M | Feb 9, 2026 | Exercise of Stock Options |
| Danahy Kevin Officer | Sep 18, 2025 | 25,000 | $406.75K | Sep 18, 2025 | Exercise of Stock Options |
| Uecker Darrin Director, Officer | Sep 11, 2025 | 120,000 | $1.77M | Sep 11, 2025 | Exercise of Stock Options |
| Uecker Darrin Officer, Director | Jun 13, 2025 | 15,000 | $239.74K | Jun 13, 2025 | Restricted stock vesting under a registered plan |
| Uecker Darrin Officer, Director | Jun 12, 2025 | 15,000 | $246.05K | Jun 12, 2025 | Restricted stock vesting under a registered plan |